SCHEMBL8790916

SCHEMBL8790916

CCc1ccc(-c2nnnn2OC(C)=O)s1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.38
MEN1 O00255 3/20 0.38
RAB9A P51151 3/20 0.38
NPC1 O15118 3/20 0.38
SMN1; SMN2 Q16637 4/20 0.35
TP53 P04637 2/20 0.35
PRNP P04156 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35
ALDH1A1 P00352 6/20 0.34
PTGS2 P35354 1/20 0.34
GRIN2B Q13224 7/20 0.34
GRIN1 Q05586 2/20 0.34
HPGD P15428 2/20 0.33
PDE5A O76074 1/20 0.33
KDM4E B2RXH2 3/20 0.33
GAA P10253 1/20 0.33
MAPT P10636 2/20 0.32
LMNA P02545 1/20 0.32
NFKB1 P19838 1/20 0.32
NFKB2 Q00653 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8791435 0.88 RPS6KB2 (0.30)
SCHEMBL8791911 0.88 MAPT (0.33) KMT2AMEN1ALDH1A1KDM4EGAA
SCHEMBL8790908 0.87 DPP4 (0.38) ALDH1A1GRIN2BGRIN1HPGDKDM4E
SCHEMBL8791239 0.85 POLB (0.38) KMT2ARAB9ANPC1SMN1; SMN2TP53
SCHEMBL8789847 0.85 DAO (0.33) KMT2AMEN1RAB9ANPC1SMN1; SMN2
SCHEMBL8790808 0.82 KDM4E (0.38) KMT2AMEN1RAB9ANPC1SMN1; SMN2
SCHEMBL8791363 0.80 NQO2 (0.42) KMT2AMEN1RAB9ANPC1SMN1; SMN2
SCHEMBL8791157 0.79 PKM (0.36) ALDH1A1HPGD
SCHEMBL8791819 0.75 KDM4E (0.38) KMT2AMEN1NPC1SMN1; SMN2TP53
SCHEMBL8790035 0.75 ALDH1A1 (0.50) KMT2AMEN1RAB9ANPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0421365-B1 Tetrazoleacetic acid derivatives having aldose reductase inhibitory activity WAKAMOTO PHARMA CO LTD (JP) 1997-03-05 EP disclosed
US-RE35321-E ANTIDIABETIC AGENT WAKAMOTO PHARMACEUTICAL CO., LTD. (JP) 1996-08-27 US disclosed
EP-0699188-A1 QUINOLINE DERIVATIVES AS LEUKOTRIENE ANTAGONISTS MERCK FROSST CANADA INC. (CA) 1996-03-06 EP disclosed
US-5068239-A Antidiabetic agent WAKAMOTO PHARMACEUTICAL CO., LTD. (JP) 1991-11-26 US disclosed
EP-0421365-A2 Tetrazoleacetic acid derivatives having aldose reductase inhibitory activity Wakamoto Pharmaceutical Co., Ltd. (JP) 1991-04-10 EP disclosed